Form 4 for LLY Lilly (Eli)
Accepted 2026-02-18 00:00:00 ET · period of report 2026-02-16 · accession 0001752447-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-18 | 2026-02-16 | LLY | Montarce Lucas | EVP, CFO | M - OptEx | $0.00 | +368 | 16.4K | +2% | $0 |
| D | 2026-02-18 | 2026-02-16 | LLY | Montarce Lucas | EVP, CFO | F - Tax | $1,040.00 | -159.73 | 16.3K | -1.0% | -$166.1K |
| D | 2026-02-18 | 2026-02-16 | LLY | Montarce Lucas | EVP, CFO | M - OptEx | $0.00 | -368 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-16 | M | A | 368 | $0.00 | 16,418.21 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-16 | F | D | 159.73 | $1,040.00 | 16,258.47 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2026-02-16 | M | D | 368 | $0.00 | 0 | D | — · 2026-02-16 to 2026-02-16 | 368 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. |